应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。
关闭
CRSP CRISPR Therapeutics AG
交易中 06-08 10:31:07 EDT
51.82
-0.02
-0.05%
最高
52.90
最低
51.13
成交量
32.60万
今开
52.71
昨收
51.84
日振幅
3.41%
总市值
49.73亿
流通市值
46.91亿
总股本
9,599万
成交额
1,689万
换手率
0.36%
流通股本
9,053万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
异动解读 | 同业公司临床试验报喜，CRISPR Therapeutics盘中大涨5.61%
异动解读 · 04-27
异动解读 | 同业公司临床试验报喜，CRISPR Therapeutics盘中大涨5.61%
Crispr Therapeutics Ag盘中异动 早盘股价大跌5.01%
市场透视 · 2025-03-10
Crispr Therapeutics Ag盘中异动 早盘股价大跌5.01%
Crispr Therapeutics Ag盘中异动 股价大跌5.00%
市场透视 · 2025-03-06
Crispr Therapeutics Ag盘中异动 股价大跌5.00%
Crispr Therapeutics Ag盘中异动 股价大涨5.03%
市场透视 · 2025-02-27
Crispr Therapeutics Ag盘中异动 股价大涨5.03%
Crispr Therapeutics Ag盘中异动 下午盘急速下跌5.00%报44.24美元
市场透视 · 2025-02-26
Crispr Therapeutics Ag盘中异动 下午盘急速下跌5.00%报44.24美元
Crispr Therapeutics Ag盘中异动 股价大跌5.03%报45.50美元
市场透视 · 2025-02-24
Crispr Therapeutics Ag盘中异动 股价大跌5.03%报45.50美元
Crispr Therapeutics Ag盘中异动 下午盘股价大跌5.02%报47.90美元
市场透视 · 2025-02-22
Crispr Therapeutics Ag盘中异动 下午盘股价大跌5.02%报47.90美元
Crispr Therapeutics Ag盘中异动 股价大涨5.15%报54.91美元
市场透视 · 2025-02-19
Crispr Therapeutics Ag盘中异动 股价大涨5.15%报54.91美元
坎托菲茨杰拉德公司：重申CRISPR Therapeutics(CRSP.US)评级，由中性调整至中性评级。
金融界 · 2025-02-19
坎托菲茨杰拉德公司：重申CRISPR Therapeutics(CRSP.US)评级，由中性调整至中性评级。
Crispr Therapeutics Ag盘中异动 大幅拉升7.18%
市场透视 · 2025-02-18
Crispr Therapeutics Ag盘中异动 大幅拉升7.18%
Crispr Therapeutics Ag2024财年实现净利润-3.66亿美元，同比减少137.66%
市场透视 · 2025-02-15
Crispr Therapeutics Ag2024财年实现净利润-3.66亿美元，同比减少137.66%
美股AI医疗股集体冲高！CRSP涨逾18%，RXRX涨逾12%
老虎资讯综合 · 2025-02-14
美股AI医疗股集体冲高！CRSP涨逾18%，RXRX涨逾12%
Crispr Therapeutics Ag盘中异动 早盘快速上涨9.31%
市场透视 · 2025-02-14
Crispr Therapeutics Ag盘中异动 早盘快速上涨9.31%
大摩：维持CRISPR Therapeutics(CRSP.US)评级，由减持调整至减持评级, 目标价由30.00美元调整至32.00美元。
金融界 · 2025-02-14
大摩：维持CRISPR Therapeutics(CRSP.US)评级，由减持调整至减持评级, 目标价由30.00美元调整至32.00美元。
高盛：维持CRISPR Therapeutics(CRSP.US)评级，由中性调整至中性评级, 目标价由66.00美元调整至57.00美元。
金融界 · 2025-02-14
高盛：维持CRISPR Therapeutics(CRSP.US)评级，由中性调整至中性评级, 目标价由66.00美元调整至57.00美元。
Chardan Capital：维持CRISPR Therapeutics(CRSP.US)评级，由买入调整至买入评级, 目标价由94.00美元调整至84.00美元。
金融界 · 2025-02-13
Chardan Capital：维持CRISPR Therapeutics(CRSP.US)评级，由买入调整至买入评级, 目标价由94.00美元调整至84.00美元。
巴克莱：维持CRISPR Therapeutics(CRSP.US)评级，由持股观望调整至持股观望评级, 目标价由55.00美元调整至56.00美元。
金融界 · 2025-02-12
巴克莱：维持CRISPR Therapeutics(CRSP.US)评级，由持股观望调整至持股观望评级, 目标价由55.00美元调整至56.00美元。
CRISPR Therapeutics 2024年第四季度GAAP每股收益$(0.44)优于预期$(1.13)，销售额$35.691M优于预期$7.657M
财报速递 · 2025-02-12
CRISPR Therapeutics 2024年第四季度GAAP每股收益$(0.44)优于预期$(1.13)，销售额$35.691M优于预期$7.657M
【木头姐、佩洛西同时押注 医疗保健是最被低估的AI应用？】“木头姐”凯西·伍德近日在接受采访及最新发布的《Big Ideas 2025》报告中多次强调，医疗保健是AI最被低估的应用领域，多组学测序和AI药物研发正成为改变医疗行业的重要创新。“我们的身体中有37万亿个细胞，它们都将被测序以寻找治疗方法。我认为AI最被低估的应用是医疗保健，医疗行业目前占据了惊人的存储量，而数据就是关键。”她表示，从长远来看，医疗保健可能会成为最深刻的AI应用，而在未来五到十年内，自动驾驶出租车可能是AI最大的应用领域。 她在报告中指出，多组学测序结合AI，可以大幅缩短药物研发周期，将新药上市时间从13年缩短至8年，成本降低4倍。通过这种技术，癌症等疾病的诊断和治疗精准度显著提升。报告预计，到2030年，AI将使药物研发和诊断效率提高数百倍，推动整个医疗行业进入高速发展期。 数据显示，木头姐的旗舰基金ARK Innovation ETF(ARKK)持有Recursion、Crispr Therapeutics、Tempus AI、Twist Bioscience和Beam Therapeutics等医疗健康股。她指出，Recursion借助AI技术使该公司研究人员平均提出假设的数量增加了10倍。 此外，前美国众议院议长佩洛西在1月14日购买了50份2026年1月到期的Tempus AI看涨期权，行权价为
金融界 · 2025-02-07
【木头姐、佩洛西同时押注 医疗保健是最被低估的AI应用？】“木头姐”凯西·伍德近日在接受采访及最新发布的《Big Ideas 2025》报告中多次强调，医疗保健是AI最被低估的应用领域，多组学测序和AI药物研发正成为改变医疗行业的重要创新。“我们的身体中有37万亿个细胞，它们都将被测序以寻找治疗方法。我认为AI最被低估的应用是医疗保健，医疗行业目前占据了惊人的存储量，而数据就是关键。”她表示，从长远来看，医疗保健可能会成为最深刻的AI应用，而在未来五到十年内，自动驾驶出租车可能是AI最大的应用领域。 她在报告中指出，多组学测序结合AI，可以大幅缩短药物研发周期，将新药上市时间从13年缩短至8年，成本降低4倍。通过这种技术，癌症等疾病的诊断和治疗精准度显著提升。报告预计，到2030年，AI将使药物研发和诊断效率提高数百倍，推动整个医疗行业进入高速发展期。 数据显示，木头姐的旗舰基金ARK Innovation ETF(ARKK)持有Recursion、Crispr Therapeutics、Tempus AI、Twist Bioscience和Beam Therapeutics等医疗健康股。她指出，Recursion借助AI技术使该公司研究人员平均提出假设的数量增加了10倍。 此外，前美国众议院议长佩洛西在1月14日购买了50份2026年1月到期的Tempus AI看涨期权，行权价为
加载更多
公司概况
公司名称：
CRISPR Therapeutics AG
所属市场：
NASDAQ
上市日期：
--
主营业务：
CRISPR Therapeutics AG作为一家瑞士股份公司在Inception Genomics AG名下于2013年10月31日注册成立。他们是一家领先的基因研究的公司，专注于CRISPR/Cas9的疗法发展。 CRISPR/ Cas9代表集群，定期相互间隔短回文重复（CRISPR）相关蛋白9，是改变基因的编排，基因组DNA的特定序列过程中的一项革命性的技术。他们正在应用此技术通过破坏，纠正或调节与疾病相关的基因来治疗广泛的稀有或常见的疾病。他们最先进的项目是针对β-地中海贫血和镰状细胞病，这种病症的治疗需要两个满足高医疗需求的血红蛋白。
发行价格：
--
{"stockData":{"symbol":"CRSP","market":"US","secType":"STK","nameCN":"CRISPR Therapeutics AG","latestPrice":51.815,"timestamp":1780929067064,"preClose":51.84,"halted":0,"volume":325951,"delay":0,"changeRate":-0.0004822530864198627,"floatShares":90533000,"shares":95985312,"eps":-6.154223,"marketStatus":"交易中","change":-0.025,"latestTime":"06-08 10:31:07 EDT","open":52.71,"high":52.9,"low":51.13,"amount":16892415.790216,"amplitude":0.034144,"askPrice":51.88,"askSize":112,"bidPrice":51.77,"bidSize":15,"shortable":0,"etf":0,"ttmEps":-6.154223,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1780948800000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1476849600000,"exchange":"NASDAQ","adjPreClose":51.84,"preHourTrading":{"tag":"盘前","latestPrice":52.91,"preClose":51.84,"latestTime":"09:27 EDT","volume":11137,"amount":584488.102639,"timestamp":1780925230012,"change":1.07,"changeRate":0.02064,"amplitude":0.030442},"postHourTrading":{"tag":"盘后","latestPrice":51.85,"preClose":51.84,"latestTime":"19:59 EDT","volume":18710,"amount":973975.0995,"timestamp":1780703950829,"change":0.01,"changeRate":0.000193,"amplitude":0.014082},"volumeRatio":1.060171,"impliedVol":0.6352,"impliedVolPercentile":0.4143},"requestUrl":"/m/hq/s/CRSP","defaultTab":"news","newsList":[{"id":"1190790849","title":"异动解读 | 同业公司临床试验报喜，CRISPR Therapeutics盘中大涨5.61%","url":"https://stock-news.laohu8.com/highlight/detail?id=1190790849","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1190790849?lang=zh_cn&edition=full","pubTime":"2026-04-27 21:34","pubTimestamp":1777296854,"startTime":"0","endTime":"0","summary":"CRISPR Therapeutics AG今日盘中股价大幅上涨5.61%，引起市场关注。同业公司英特利亚疗法宣布，其用于治疗罕见水肿疾病的CRISPR基因编辑疗法在三期临床试验中达到主要终点，成为全球首款针对活体体内CRISPR基因编辑且获得三期临床阳性数据的疗法，标志着该技术领域的一个重要里程碑。这一积极进展提振了投资者对整个CRISPR基因编辑行业的信心，可能带动了包括CRISPR Therapeutics在内的相关公司股价上扬。目前，FDA唯一获批的CRISPR药物是由福泰制药研发的体外编辑疗法Casgevy。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["CRSP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518203826","title":"Crispr Therapeutics Ag盘中异动 早盘股价大跌5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518203826","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518203826?lang=zh_cn&edition=full","pubTime":"2025-03-10 22:49","pubTimestamp":1741618153,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日22时49分，Crispr Therapeutics Ag股票出现异动，股价大幅下跌5.01%。Crispr Therapeutics Ag股票所在的生物技术行业中，整体涨幅为0.22%。Crispr Therapeutics Ag公司简介：CRISPR Therapeutics AG是一家基因编辑公司，专注于开发基于Crispr/Cas9的疗法。Crispr/Cas9是成簇的规则间隔短回文重复序列/Crispr相关蛋白9的缩写，是精确改变基因组DNA特定序列的革命性技术。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031022491398a2b016&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031022491398a2b016&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4611","LU1861558580.USD","BK4585","BK4556","BK4588","CRSP","LU1861559042.SGD","LENZ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517016551","title":"Crispr Therapeutics Ag盘中异动 股价大跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517016551","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517016551?lang=zh_cn&edition=full","pubTime":"2025-03-06 22:41","pubTimestamp":1741272079,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日22时41分，Crispr Therapeutics Ag股票出现异动，股价快速下挫5.00%。Crispr Therapeutics Ag股票所在的生物技术行业中，整体跌幅为0.41%。Crispr Therapeutics Ag公司简介：CRISPR Therapeutics AG是一家基因编辑公司，专注于开发基于Crispr/Cas9的疗法。Crispr/Cas9是成簇的规则间隔短回文重复序列/Crispr相关蛋白9的缩写，是精确改变基因组DNA特定序列的革命性技术。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306224120963c4f33&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306224120963c4f33&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4588","LU1861558580.USD","CRSP","LU1861559042.SGD","BK4585","BK4556","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514381222","title":"Crispr Therapeutics Ag盘中异动 股价大涨5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514381222","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514381222?lang=zh_cn&edition=full","pubTime":"2025-02-27 23:11","pubTimestamp":1740669085,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日23时11分，Crispr Therapeutics Ag股票出现异动，股价大幅上涨5.03%。Crispr Therapeutics Ag股票所在的生物技术行业中，整体涨幅为0.79%。Crispr Therapeutics Ag公司简介：CRISPR Therapeutics AG是一家基因编辑公司，专注于开发基于Crispr/Cas9的疗法。Crispr/Cas9是成簇的规则间隔短回文重复序列/Crispr相关蛋白9的缩写，是精确改变基因组DNA特定序列的革命性技术。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502272311259632ba0a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502272311259632ba0a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1861558580.USD","BK4556","LENZ","BK4588","LU1861559042.SGD","BK4139","CRSP","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514043687","title":"Crispr Therapeutics Ag盘中异动 下午盘急速下跌5.00%报44.24美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514043687","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514043687?lang=zh_cn&edition=full","pubTime":"2025-02-26 03:14","pubTimestamp":1740510850,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日03时14分，Crispr Therapeutics Ag股票出现波动，股价急速下跌5.00%。截至发稿，该股报44.24美元/股，成交量135.121万股，换手率1.58%，振幅5.11%。Crispr Therapeutics Ag股票所在的生物技术行业中，整体跌幅为0.16%。Crispr Therapeutics Ag公司简介：CRISPR Therapeutics AG是一家基因编辑公司，专注于开发基于Crispr/Cas9的疗法。Crispr/Cas9是成簇的规则间隔短回文重复序列/Crispr相关蛋白9的缩写，是精确改变基因组DNA特定序列的革命性技术。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022603141096302785&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022603141096302785&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1861558580.USD","CRSP","LU1861559042.SGD","BK4139","BK4585","LENZ","BK4556","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513772084","title":"Crispr Therapeutics Ag盘中异动 股价大跌5.03%报45.50美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513772084","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513772084?lang=zh_cn&edition=full","pubTime":"2025-02-24 23:03","pubTimestamp":1740409397,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日23时03分，Crispr Therapeutics Ag股票出现波动，股价急速跳水5.03%。截至发稿，该股报45.50美元/股，成交量50.3026万股，换手率0.59%，振幅4.18%。Crispr Therapeutics Ag股票所在的生物技术行业中，整体涨幅为0.34%。Crispr Therapeutics Ag公司简介：CRISPR Therapeutics AG是一家基因编辑公司，专注于开发基于Crispr/Cas9的疗法。Crispr/Cas9是成簇的规则间隔短回文重复序列/Crispr相关蛋白9的缩写，是精确改变基因组DNA特定序列的革命性技术。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502242303179890fdaf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502242303179890fdaf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4556","LENZ","BK4585","CRSP","BK4588","LU1861559042.SGD","BK4139","LU1861558580.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513219328","title":"Crispr Therapeutics Ag盘中异动 下午盘股价大跌5.02%报47.90美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513219328","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513219328?lang=zh_cn&edition=full","pubTime":"2025-02-22 03:00","pubTimestamp":1740164429,"startTime":"0","endTime":"0","summary":"北京时间2025年02月22日03时00分，Crispr Therapeutics Ag股票出现异动，股价急速下挫5.02%。截至发稿，该股报47.90美元/股，成交量153.512万股，换手率1.79%，振幅7.02%。Crispr Therapeutics Ag股票所在的生物技术行业中，整体涨幅为0.43%。Crispr Therapeutics Ag公司简介：CRISPR Therapeutics AG是一家基因编辑公司，专注于开发基于Crispr/Cas9的疗法。Crispr/Cas9是成簇的规则间隔短回文重复序列/Crispr相关蛋白9的缩写，是精确改变基因组DNA特定序列的革命性技术。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222030029988e16bc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222030029988e16bc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1861558580.USD","CRSP","LU1861559042.SGD","BK4139","BK4585","LENZ","BK4556","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512486511","title":"Crispr Therapeutics Ag盘中异动 股价大涨5.15%报54.91美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512486511","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512486511?lang=zh_cn&edition=full","pubTime":"2025-02-19 23:17","pubTimestamp":1739978246,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日23时17分，Crispr Therapeutics Ag股票出现波动，股价急速拉升5.15%。截至发稿，该股报54.91美元/股，成交量120.4万股，换手率1.40%，振幅4.96%。Crispr Therapeutics Ag股票所在的生物技术行业中，整体涨幅为0.50%。Crispr Therapeutics Ag公司简介：CRISPR Therapeutics AG是一家基因编辑公司，专注于开发基于Crispr/Cas9的疗法。Crispr/Cas9是成簇的规则间隔短回文重复序列/Crispr相关蛋白9的缩写，是精确改变基因组DNA特定序列的革命性技术。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502192317269628d551&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502192317269628d551&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRSP","LU1861559042.SGD","BK4556","BK4588","LENZ","BK4139","LU1861558580.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512483048","title":"坎托菲茨杰拉德公司：重申CRISPR Therapeutics(CRSP.US)评级，由中性调整至中性评级。","url":"https://stock-news.laohu8.com/highlight/detail?id=2512483048","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512483048?lang=zh_cn&edition=full","pubTime":"2025-02-19 22:57","pubTimestamp":1739977034,"startTime":"0","endTime":"0","summary":"坎托菲茨杰拉德公司：重申CRISPR Therapeutics(CRSP.US)评级，由中性调整至中性评级。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/19225748267091.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LENZ","CRSP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512316553","title":"Crispr Therapeutics Ag盘中异动 大幅拉升7.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512316553","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512316553?lang=zh_cn&edition=full","pubTime":"2025-02-18 22:35","pubTimestamp":1739889322,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日22时35分，Crispr Therapeutics Ag股票出现异动，股价大幅上涨7.18%。Crispr Therapeutics Ag股票所在的生物技术行业中，整体涨幅为0.02%。其相关个股中，Solid Biosciences Inc.、Revolution Medicines Inc C/Wts 17/12/2026 、Aditxt, Inc.涨幅较大，Aditxt, Inc.、Solid Biosciences Inc.、Moleculin Biotech, Inc.较为活跃，换手率分别为284.26%、100.36%、75.51%，振幅较大的相关个股有Jasper Therapeutics Inc C/Wts 24/09/2026 、Allogene Therapeutics, Inc.、Glycomimetics, Inc.，振幅分别为34.04%、22.30%、18.69%。Crispr Therapeutics Ag公司简介：Crispr Therapeutics是一家基因编辑公司，专注于开发基于CRISPR/Cas9的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218223523962797fc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218223523962797fc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4139","BK4588","LU1861559042.SGD","LU1861558580.USD","BK4556","LENZ","CRSP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511697358","title":"Crispr Therapeutics Ag2024财年实现净利润-3.66亿美元，同比减少137.66%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511697358","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511697358?lang=zh_cn&edition=full","pubTime":"2025-02-15 00:00","pubTimestamp":1739548849,"startTime":"0","endTime":"0","summary":"2月15日，Crispr Therapeutics Ag公布财报，公告显示公司2024财年净利润为-3.66亿美元，同比减少137.66%；其中营业收入为37.31百万美元，同比减少89.94%，每股基本收益为-4.34美元。从资产负债表来看，Crispr Therapeutics Ag总负债3.10亿美元，其中短期债务17.29百万美元，资产负债比为7.24，流动比率为0.23。机构评级：截至2025年2月15日，当前有27家机构对Crispr Therapeutics Ag目标价做出预测，其中目标均价为79.15美元，其中最低目标价为32.00美元，最高目标价为268.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250215000120abcf1afe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250215000120abcf1afe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","CRSP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1110855036","title":"美股AI医疗股集体冲高！CRSP涨逾18%，RXRX涨逾12%","url":"https://stock-news.laohu8.com/highlight/detail?id=1110855036","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1110855036?lang=zh_cn&edition=full","pubTime":"2025-02-14 22:58","pubTimestamp":1739545122,"startTime":"0","endTime":"0","summary":"2月14日，美股AI医疗股集体冲高，CRSP涨逾18%，RXRX涨逾12%，TEM涨近6%，HIMS涨逾4%。","market":"us","thumbnail":"https://static.tigerbbs.com/fd680cd945fd32917c8ece66ec685e5f","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/fd680cd945fd32917c8ece66ec685e5f"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"ea36134c67825b5593d26a5d4f14b862","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRSP","RXRX","HIMS","TEM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511469908","title":"Crispr Therapeutics Ag盘中异动 早盘快速上涨9.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511469908","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511469908?lang=zh_cn&edition=full","pubTime":"2025-02-14 22:31","pubTimestamp":1739543511,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日22时31分，Crispr Therapeutics Ag股票出现异动，股价大幅上涨9.31%。Crispr Therapeutics Ag股票所在的生物技术行业中，整体涨幅为0.18%。其相关个股中，Moleculin Biotech, Inc.、Virpax Pharmaceuticals, Inc.、Cns Pharmaceuticals, Inc.涨幅较大，Moleculin Biotech, Inc.、Virpax Pharmaceuticals, Inc.、Cns Pharmaceuticals, Inc.较为活跃，换手率分别为1008.86%、360.55%、328.49%，振幅较大的相关个股有Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Theratechnologies Inc.、Virpax Pharmaceuticals, Inc.，振幅分别为20.20%、18.33%、15.20%。Crispr Therapeutics Ag公司简介：Crispr Therapeutics是一家基因编辑公司，专注于开发基于CRISPR/Cas9的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214223151abcf0677&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214223151abcf0677&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1861558580.USD","CRSP","LU1861559042.SGD","BK4139","BK4585","LENZ","BK4556","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511953096","title":"大摩：维持CRISPR Therapeutics(CRSP.US)评级，由减持调整至减持评级, 目标价由30.00美元调整至32.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2511953096","media":"金融界","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511953096?lang=zh_cn&edition=full","pubTime":"2025-02-14 22:12","pubTimestamp":1739542347,"startTime":"0","endTime":"0","summary":"大摩：维持CRISPR Therapeutics(CRSP.US)评级，由减持调整至减持评级, 目标价由30.00美元调整至32.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/14221248178050.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["CRSP","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511857368","title":"高盛：维持CRISPR Therapeutics(CRSP.US)评级，由中性调整至中性评级, 目标价由66.00美元调整至57.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2511857368","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511857368?lang=zh_cn&edition=full","pubTime":"2025-02-14 01:34","pubTimestamp":1739468064,"startTime":"0","endTime":"0","summary":"高盛：维持CRISPR Therapeutics(CRSP.US)评级，由中性调整至中性评级, 目标价由66.00美元调整至57.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/14013448150586.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LENZ","CRSP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511510073","title":"Chardan Capital：维持CRISPR Therapeutics(CRSP.US)评级，由买入调整至买入评级, 目标价由94.00美元调整至84.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2511510073","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511510073?lang=zh_cn&edition=full","pubTime":"2025-02-13 18:53","pubTimestamp":1739443989,"startTime":"0","endTime":"0","summary":"Chardan Capital：维持CRISPR Therapeutics(CRSP.US)评级，由买入调整至买入评级, 目标价由94.00美元调整至84.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/13185348145389.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LENZ","CRSP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510373963","title":"巴克莱：维持CRISPR Therapeutics(CRSP.US)评级，由持股观望调整至持股观望评级, 目标价由55.00美元调整至56.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2510373963","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510373963?lang=zh_cn&edition=full","pubTime":"2025-02-12 20:11","pubTimestamp":1739362270,"startTime":"0","endTime":"0","summary":"巴克莱：维持CRISPR Therapeutics(CRSP.US)评级，由持股观望调整至持股观望评级, 目标价由55.00美元调整至56.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/12201148119912.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LENZ","CRSP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1128023703","title":"CRISPR Therapeutics 2024年第四季度GAAP每股收益$(0.44)优于预期$(1.13)，销售额$35.691M优于预期$7.657M","url":"https://stock-news.laohu8.com/highlight/detail?id=1128023703","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1128023703?lang=zh_cn&edition=full","pubTime":"2025-02-12 05:27","pubTimestamp":1739309251,"startTime":"0","endTime":"0","summary":"CRISPR Therapeutics报告其季度每股亏损$，优于分析师预期的$，超出预期61.06%。与去年同期的每股收益$1.10相比，下降了140%。公司季度销售额为$35.691百万，超出分析师预期的$7.657百万，超出预期366.13%。以上内容来自Benzinga Earnings专栏，原文如下：CRISPR $Therapeutics$ reported quarterly losses of $ per share which beat the analyst consensus estimate of $ by 61.06 percent. This is a 140 percent decrease over earnings of $1.10 per share from the same period last year. The company reported quarterly sales of $35.691 million which beat the analyst consensus estimate of $7.657 million by ","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","CRSP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509766383","title":"【木头姐、佩洛西同时押注 医疗保健是最被低估的AI应用？】“木头姐”凯西·伍德近日在接受采访及最新发布的《Big Ideas 2025》报告中多次强调，医疗保健是AI最被低估的应用领域，多组学测序和AI药物研发正成为改变医疗行业的重要创新。“我们的身体中有37万亿个细胞，它们都将被测序以寻找治疗方法。我认为AI最被低估的应用是医疗保健，医疗行业目前占据了惊人的存储量，而数据就是关键。”她表示，从长远来看，医疗保健可能会成为最深刻的AI应用，而在未来五到十年内，自动驾驶出租车可能是AI最大的应用领域。 她在报告中指出，多组学测序结合AI，可以大幅缩短药物研发周期，将新药上市时间从13年缩短至8年，成本降低4倍。通过这种技术，癌症等疾病的诊断和治疗精准度显著提升。报告预计，到2030年，AI将使药物研发和诊断效率提高数百倍，推动整个医疗行业进入高速发展期。 数据显示，木头姐的旗舰基金ARK Innovation ETF(ARKK)持有Recursion、Crispr Therapeutics、Tempus AI、Twist Bioscience和Beam Therapeutics等医疗健康股。她指出，Recursion借助AI技术使该公司研究人员平均提出假设的数量增加了10倍。 此外，前美国众议院议长佩洛西在1月14日购买了50份2026年1月到期的Tempus AI看涨期权，行权价为","url":"https://stock-news.laohu8.com/highlight/detail?id=2509766383","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509766383?lang=zh_cn&edition=full","pubTime":"2025-02-07 13:58","pubTimestamp":1738907896,"startTime":"0","endTime":"0","summary":"“木头姐”凯西·伍德近日在接受采访及最新发布的《Big Ideas 2025》报告中多次强调，医疗保健是AI最被低估的应用领域，多组学测序和AI药物研发正成为改变医疗行业的重要创新。她表示，从长远来看，医疗保健可能会成为最深刻的AI应用，而在未来五到十年内，自动驾驶出租车可能是AI最大的应用领域。她在报告中指出，多组学测序结合AI，可以大幅缩短药物研发周期，将新药上市时间从13年缩短至8年，成本降低4倍。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/07135848009030.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK4121","LENZ","CRSP","BK4585","LU1861559042.SGD","BK4556","BK4550","LU1861558580.USD","BK4139","159760","BK4544","FDN","ARKK","BK4588","159891","TEM"],"isVideo":false,"video":null,"gpt_icon":1}],"profile":{"websiteUrl":"http://www.crisprtx.com;crisprtx.gcs-web.com","stockEarnings":[{"period":"1week","weight":-0.0773},{"period":"1month","weight":-0.0588},{"period":"3month","weight":-0.0825},{"period":"6month","weight":-0.0886},{"period":"1year","weight":0.344},{"period":"ytd","weight":-0.0114}],"compareEarnings":[{"period":"1week","weight":-0.025},{"period":"1month","weight":0.0051},{"period":"3month","weight":0.0969},{"period":"6month","weight":0.0756},{"period":"1year","weight":0.2437},{"period":"ytd","weight":0.0816}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"CRISPR Therapeutics AG作为一家瑞士股份公司在Inception Genomics AG名下于2013年10月31日注册成立。他们是一家领先的基因研究的公司，专注于CRISPR/Cas9的疗法发展。 CRISPR/ Cas9代表集群，定期相互间隔短回文重复（CRISPR）相关蛋白9，是改变基因的编排，基因组DNA的特定序列过程中的一项革命性的技术。他们正在应用此技术通过破坏，纠正或调节与疾病相关的基因来治疗广泛的稀有或常见的疾病。他们最先进的项目是针对β-地中海贫血和镰状细胞病，这种病症的治疗需要两个满足高医疗需求的血红蛋白。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.073064},{"month":2,"riseRate":0.7,"avgChangeRate":0.097632},{"month":3,"riseRate":0.2,"avgChangeRate":-0.105212},{"month":4,"riseRate":0.7,"avgChangeRate":0.005611},{"month":5,"riseRate":0.6,"avgChangeRate":0.087312},{"month":6,"riseRate":0.7,"avgChangeRate":0.105248},{"month":7,"riseRate":0.777778,"avgChangeRate":0.040401},{"month":8,"riseRate":0.444444,"avgChangeRate":-0.01221},{"month":9,"riseRate":0.222222,"avgChangeRate":-0.057837},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.045012},{"month":11,"riseRate":0.7,"avgChangeRate":0.172836},{"month":12,"riseRate":0.2,"avgChangeRate":-0.065489}],"exchange":"NASDAQ","name":"CRISPR Therapeutics AG","nameEN":"CRISPR Therapeutics AG"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"CRISPR Therapeutics AG(CRSP)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供CRISPR Therapeutics AG(CRSP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"CRISPR Therapeutics AG,CRSP,CRISPR Therapeutics AG股票,CRISPR Therapeutics AG股票老虎,CRISPR Therapeutics AG股票老虎国际,CRISPR Therapeutics AG行情,CRISPR Therapeutics AG股票行情,CRISPR Therapeutics AG股价,CRISPR Therapeutics AG股市,CRISPR Therapeutics AG股票价格,CRISPR Therapeutics AG股票交易,CRISPR Therapeutics AG股票购买,CRISPR Therapeutics AG股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"CRISPR Therapeutics AG(CRSP)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供CRISPR Therapeutics AG(CRSP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}